Company / CapEx per Share
Spyre Therapeutics, Inc. CapEx per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
-
FY2024
5-year range
$0.00 / $0.09
FY2020-FY2024
Trend
-
vs FY2023
Sector context
#188 of 192
Health Care
What the data says
Declined from $0.09 to $0.00 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 192
▼
Key checks
Key Insights
- Peak capex per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.00 | - |
| FY2023 | $0.00 | -100.0% |
| FY2022 | $0.09 | +625.8% |
| FY2021 | $0.01 | -17.7% |
| FY2020 | $0.01 | -43.4% |
| FY2019 | $0.03 | +101.6% |
| FY2018 | $0.01 | -68.9% |
| FY2017 | $0.04 | +89.0% |
| FY2016 | $0.02 | -93.8% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026